Mechanisms of PARP inhibitor resistance in ovarian cancer.

Kubalanza, Kari; Konecny, Gottfried E

Kubalanza, Kari; Konecny, Gottfried E.

Affiliation

Kubalanza K; Division of Hematology/Oncology, Department of Medicine.
Konecny GE; Division of Hematology/Oncology, Department of Medicine.

Curr Opin Obstet Gynecol ; 32(1): 36-41, 2020 02.

Article in En | MEDLINE | ID: mdl-31815769

Subject(s)

Carcinoma, Ovarian Epithelial/drug therapy; Drug Resistance, Neoplasm/drug effects; Ovarian Neoplasms/drug therapy; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology; Animals; BRCA1 Protein/drug effects; BRCA2 Protein/drug effects; Female; Homologous Recombination/drug effects; Humans; Mice; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Drug Resistance, Neoplasm / Poly(ADP-ribose) Polymerase Inhibitors / Carcinoma, Ovarian Epithelial Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Curr Opin Obstet Gynecol Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google